Teladoc Health Q2 revenue misses estimates as BetterHelp cash pay declined
Teladoc Health Q2 revenue misses estimates as BetterHelp cash pay declined
Overview
Virtual care provider's Q2 revenue fell 4% yr/yr, missing analyst expectations
Q2 adjusted EBITDA beat analyst expectations despite a 5% yr/yr decline
Company cites BetterHelp cash pay decline and insurance shift as key revenue drivers
Outlook
Teladoc Health sees full-year 2026 revenue between $2.36 bln and $2.45 bln
Company expects BetterHelp segment revenue to decline 13% to 19% in 2026
Teladoc Health anticipates 3Q 2026 revenue between $569 mln and $609 mln
Result Drivers
BETTERHELP CASH PAY DECLINE - Co said accelerated decline in BetterHelp cash pay revenue weighed on overall results
INSURANCE DEMAND AND PROVIDER CAPACITY - Co said stronger than anticipated demand for insurance-covered BetterHelp services outpaced available provider capacity, limiting revenue conversion
INTEGRATED CARE GROWTH - Integrated Care segment posted modest revenue growth and improved adjusted EBITDA margin
Company press release: ID:nGNX1F8wqd
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Revenue | Miss | $606.93 mln | $615.39 mln (21 Analysts) |
Q2 Loss Per Share |
| $0.21 |
|
Q2 Net Loss |
| $38.91 mln |
|
Q2 Adjusted EBITDA | Beat | $65.71 mln | $61.97 mln (21 Analysts) |
Q2 Loss Per Basic Share |
| $0.21 |
|
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 6 "strong buy" or "buy", 19 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the healthcare facilities & services peer group is "buy."
Wall Street's median 12-month price target for Teladoc Health Inc is $7.00, about 25.2% below its July 28 closing price of $9.36
Reuters Recommended Reads
July 28 - Acadia Healthcare Q2 revenue beats in inpatient growth but costs bite
July 29 - US FTC sues Hims & Hers for sending user health info to Meta, Snap
July 28 - Chemed Q2 revenue beats estimates, helped by VITAS segment growth
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on Teladoc Health
See all newsTeladoc appoints insurance executive Michael Grasher as CFO
U.S. STOCKS ON THE MOVE-Mastercard, Yum, Equinix
U.S. STOCKS ON THE MOVE-Mastercard, Starbucks, Meta
Teladoc tumbles on revenue forecast cut as BetterHelp demand shifts hurt (updated)
U.S. STOCKS ON THE MOVE-Avery Dennison, Huntington Ingalls, XPO